Medicine
Adenosine 6 mg/2 mL injection
Adenosine 6 mg/2 mL injection is a generic prescription medicine for intravenous use, made by 9 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
DO NOT REFRIGERATE as crystallization may occur. Store at 20° to 25°C (68° to…
Key facts
- Active ingredient (INN)
- Adenosine
- Brand
- Sold under the generic name
- Strength
- 6 mg/2 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 10 syringes of 2 mL, 10 vials of 2 mL, 2 mL and 14 more
- Manufacturers
- Gland PharmaIndiaHealthFirstFresenius KabiMedical Purchasing SolutionsMylan InstitutionalProPharma DistributionSagent PharmaceuticalsHenry ScheinRemedyrepack
- Origin register
- US FDA, United States
- Storage
- DO NOT REFRIGERATE as crystallization may occur. Store at 20° to 25°C (68° to 77°F). If crystallization has occurred, dissolve crystals by warming to room temperature.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C01EB10 Adenosine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 23 November 2005
- Identifiers
- RxCUI 1654169, 727355, 727360 +3DailyMed set ID 296af833-5724-3e23-e063-6394a90a6251, 5a55b45d-9cee-4c0c-9e44-021dbf70a018, 48d72391-b3d4-bd97-e063-6294a90a9d6f +14NDC 71872-7335, 25021-301, 84549-031 +13Application ANDA206778, ANDA077283, ANDA077133 +2
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 syringe in 1 carton / 2 mL in 1 syringe | 68083-101-01 | Gland PharmaIndia | 1 April 2013 |
| 10 vial in 1 carton / 2 mL in 1 vial | 68083-156-10 | Gland PharmaIndia | 13 January 2017 |
| 10 vial, single-use in 1 tray / 2 mL in 1 vial, single-use | 63323-651-02 | Fresenius Kabi | 23 November 2005 |
| 10 syringe, plastic in 1 carton / 2 mL in 1 syringe, plastic | 63323-651-89 | Fresenius Kabi | 16 April 2018 |
| 10 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 67457-855-02 | Mylan Institutional | 8 May 2018 |
| 10 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 72078-033-02 | Mylan Institutional | 6 April 2022 |
| 10 syringe in 1 carton / 2 mL in 1 syringe | 25021-301-67 | Sagent Pharmaceuticals | 16 April 2014 |
| 10 vial in 1 carton / 2 mL in 1 vial | 25021-318-02 | Sagent Pharmaceuticals | 15 March 2023 |
| 2 mL in 1 vial, single-dose | 51662-1631-1 | HealthFirst | 28 April 2023 |
| 2 mL in 1 vial, single-use | 51662-1632-1 | HealthFirst | 23 June 2023 |
| 10 pouch in 1 case / 1 syringe in 1 pouch / 2 mL in 1 syringe | 51662-1643-3 | HealthFirst | 16 April 2018 |
| 1 vial, single-dose in 1 bag / 2 mL in 1 vial, single-dose | 71872-7209-1 | Medical Purchasing Solutions | 30 March 2020 |
| 1 vial in 1 bag / 2 mL in 1 vial | 71872-7335-1 | Medical Purchasing Solutions | 25 November 2024 |
| 2 mL in 1 syringe | 84549-031-67 | ProPharma Distribution | 8 January 2026 |
| 2 mL in 1 vial | 84549-318-02 | ProPharma Distribution | 27 August 2025 |
| 1 vial, single-use in 1 bag / 2 mL in 1 vial, single-use | 0404-9993-02 | Henry Schein | 28 June 2023 |
| 10 vial in 1 carton / 2 mL in 1 vial | 70518-4207-0 | Remedyrepack | 10 October 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 30 October 1989 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Adenosine
Clinical summary
Adenosine is an adenosine receptor agonist indicated for the following. It is available as injection for intravenous use. MedsAcross supplies Adenosine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about AdenosineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Adenosine prescribing information (Sagent Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Adenosine 6 mg/2 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.